A comprehensive analysis of phenotypic and functional characteristics of NK cells at DLBCL diagnosis followed by RTX treatment revealed that the initial high level of NK CD16-positive cells including CD56dim population decreased over the course of therapy, whereas the expression of activating receptors (CD16, NKG2D) was diminished [36]. Here, FCGR3A is linked to diffuse large B-cell lymphoma.